Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
09/2010
09/15/2010CN101134742B Method for synthesizing 2,2'-biquinoline
09/14/2010US7795471 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates
09/14/2010US7795437 Ether derivatives
09/14/2010US7795315 N-(2-amino-phenyl)-amide derivatives
09/14/2010US7795272 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
09/14/2010CA2394276C Serine protease inhibitors
09/10/2010WO2010101949A1 8-substituted quinolines and related analogs as sirtuin modulators
09/10/2010WO2010100475A1 Hydroxamic acid derivatives as gram-negative antibacterial agents
09/10/2010WO2010042163A3 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
09/10/2010CA2754058A1 8-substituted quinolines and related analogs as sirtuin modulators
09/09/2010US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
09/09/2010US20100228008 Dyes linked to target molecules, oligonucleotides or polynucleotides comprising dye molecules, composite dyes and other compositions useful for detecting or quantifying desirable target molecules
09/09/2010US20100227884 Amide compounds and plant disease controlling method using same
09/09/2010US20100226882 Linked diimidazole antivirals
09/08/2010EP2224926A1 Prolyl hydroxylase inhibitors
09/08/2010EP1399190B1 Pharmaceutical compositions comprising low-solubility and acid-sensitive drugs and neutralized acidic polymers
09/08/2010EP0882717B1 Nitrogenous heterocyclic compounds
09/08/2010CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
09/08/2010CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
09/08/2010CN101827854A Transition metal complex and process for producing conjugated aromatic compound with the transition metal complex
09/08/2010CN101827817A Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides
09/08/2010CN101823998A Pollution-free production process for ethoxy quinoline by coupling reactor and simulation moving bed
09/08/2010CN101823997A Preparation method of 2-bit acyl substituted quinoline
09/08/2010CN101823996A Preparation method of 2,8-bit acyl substituted quinoline
09/08/2010CN101823987A New DPP-IV inhibitors and preparation method and application thereof
09/08/2010CN101412695B Quinoline derivatives having antimycotic activity and preparation thereof
09/08/2010CN101337930B Urea derivative preparation process
09/07/2010US7790896 RNA-selective probes for live cell imaging of nuclear structure and function
09/07/2010US7790895 Quinoline derivatives as potassium ion channel openers
09/07/2010US7790894 Mycobacterial inhibitors
09/07/2010US7790893 incorporating indolium ring moiety substituted at 3-position improves spectral properties; for detection of ligands; hybridization probes
09/07/2010US7790892 Aromatic compound and organic electroluminescent element containing the same
09/07/2010CA2375810C Beta2-adrenoceptor agonists
09/02/2010WO2010098583A2 Novel method for preparing statin compounds or salts thereof, and intermediate compounds used in same
09/02/2010US20100222381 Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
09/02/2010US20100222380 Modified Chalcone Compounds as Antimitotic Agents
09/02/2010US20100222379 Novel histone deacetylase inhibitors
09/02/2010US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222347 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient
09/02/2010US20100222346 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
09/02/2010US20100222338 Beta-secretase modulators and methods of use
09/02/2010US20100222330 New Compounds
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/01/2010EP2223910A1 Oxime esters and photopolymerization initiators containing the same
09/01/2010EP2222631A2 Substituted phenylmethyl bicyclocarboxyamide compounds
09/01/2010EP2222304A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
09/01/2010EP2222287A2 Multitarget compounds active at a ppar and cannabinoid receptor
09/01/2010EP2057122B1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor
09/01/2010EP2019825B1 Inhibitors of human immunodeficiency virus replication
09/01/2010EP1854787B1 Novel cyclic compound having quinolylalkylthio group
09/01/2010EP1814857B1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands
09/01/2010EP1560488B1 Antibacterial agents
09/01/2010EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/01/2010EP1285651B1 Melanin concentrating hormone antagonists
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN101821223A Process and intermediates for preparing integrase inhibitors
09/01/2010CN101818056A Dansyl molecular probe and synthetic method and application thereof
09/01/2010CN101817818A Compound used for preparing montelukast sodium
09/01/2010CN101817815A Compounds with antibacterial activity
09/01/2010CN101817799A Cyanoacrylate compound and application thereof in pesticide and medicine
09/01/2010CN101817767A Substituted sulphonamide compound and preparation method, medicine composition and application thereof
09/01/2010CN101337928B Quinoline compounds, synthesizing method, applications in synthesis of alkaloid of camptothecins
08/2010
08/31/2010US7786177 Phenylalanine enamide derivatives
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786139 phosphodiesterase inhibitors such as (E)-N'-(3,4-dimethoxybenzylidene)-2-(2-methylquinolin-4-ylthio)acetohydrazide, used for the treatment of psychological disorders, nervous system disorders, sleep disorders and as analgesic or anxiolytic agents
08/31/2010US7786138 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786116 2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)
08/26/2010WO2010094484A1 5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino}-l-hydroxyethyl) -8-hydroxyquin olin-2 (1h)-one and its use in the treatment of pulmonary diseases
08/26/2010WO2010094242A1 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
08/26/2010WO2010064109A3 An improved process for the preparation of montelukast sodium and its intermediates
08/26/2010WO2009038683A3 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/26/2010US20100217004 Process for the production of tertiary alcohols
08/26/2010US20100216998 Facile "One Pot' Process for Apomorphine From Codeine
08/26/2010US20100216837 Glycine transport inhibitors
08/26/2010US20100216803 Ornithine derivative
08/26/2010US20100216786 New compounds
08/26/2010US20100216770 Inhibitors of the Interaction Between MDM2 and P53
08/26/2010US20100215710 Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing
08/26/2010US20100215579 Phen-naphthalene and phen-quinoline derivatives and their use for binding and imaging amyloid plaques
08/26/2010CA2749045A1 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquin olin-2(1h)-one and its use in the treatment of pulmonary diseases
08/25/2010EP2221297A1 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
08/25/2010EP2220076A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220047A2 Compounds and methods
08/25/2010EP2220046A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2010496B1 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors
08/25/2010CN101815703A 新颖的杀真菌剂 Novel fungicide
08/25/2010CN101815700A Derivatives of 4-(2-amino-1 -hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
08/25/2010CN101812017A CHF4226 in crystalline form and the process for its preparation
08/25/2010CN101429157B Process for producing 2-methyl-8-nitryl quinoline
08/25/2010CN101143845B Substituted quinoline formyl guanidine derivative, its preparation method and medical use
08/24/2010US7781628 in which an organic thin film layer comprising a single layer or plural layers including at least a light emitting layer is sandwiched between a cathode and an anode; high luminous efficiency
08/24/2010US7781589 Quantitative method of determining beryllium or a compound thereof in a sample
08/24/2010US7781585 Crystalline forms of Gatifloxacin
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010US7781458 Derivatives of pyridine and quinoline
08/24/2010CA2459752C 3-aminocarbonyl-substituted benzoylcyclohexanediones which can be used as herbicides
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010075280A3 Coumarin-based compounds for the treatment of alzheimer's disease and cancer
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 277